Wellbiotec Co. Ltd. (010600) — Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Wellbiotec Co. Ltd. (010600) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow (₩2.72 Billion) in capital expenditures (₩10.89 Million). See 010600 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.72 Billion
KRW

Capital Expenditures

₩10.89 Million
KRW

Data as of

Sep 2024
Most recent filing

Wellbiotec Co. Ltd. Capital Reinvestment Ratio (2005–2022)

This chart tracks Wellbiotec Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. Check 010600 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Wellbiotec Co. Ltd. (2005–2022)

Year-by-year Capital Reinvestment Ratio for Wellbiotec Co. Ltd. from 2005 to 2022. For live market cap and broader valuation context, see Wellbiotec Co. Ltd. (010600) market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 0.19x ₩2.62 Billion ₩508.76 Million ▼ -75.6%
2021 0.79x ₩712.97 Million ₩565.92 Million ▲ +259.3%
2015 0.22x ₩4.28 Billion ₩944.92 Million ▼ -20.8%
2013 0.28x ₩1.01 Billion ₩281.62 Million ▲ +3.1%
2012 0.27x ₩3.06 Billion ₩826.93 Million ▲ +80.2%
2010 0.15x ₩2.90 Billion ₩435.67 Million ▼ -94.0%
2008 2.51x ₩3.11 Billion ₩7.82 Billion ▲ +212.3%
2006 0.81x ₩4.49 Billion ₩3.62 Billion ▼ -79.2%
2005 3.87x ₩1.48 Billion ₩5.72 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow